Researcher.Life Logo

Current Oncology : Impact Factor & More

eISSN: 1718-7729pISSN: 1198-0052
JournalOpen Access

Key Metrics

CiteScore
3.5
Impact Factor
< 5
Scite Index
0.86 5-Year SI
SNIP
1.14
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Oncology

Current Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher MDPI
Language English
Frequency Monthly
Article Processing ChargesCHF 1800
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Current Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Oncology

CDKN2A/p16 Exon 2 Hypermethylation in Lung Squamous Cell Carcinoma Associated with Interstitial and Emphysematous Lung Diseases: A Comparative Analysis of Tumor, Adjacent and Distant Lung Tissues.
  • 27 Mar 2026
  • Current oncology (Toronto, Ont.)
E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progression.
  • 26 Mar 2026
  • Current oncology (Toronto, Ont.)
Real-World Outcomes of First-Line Cetuximab and Platinum-Based Chemotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Observational Study and Literature Review.
  • 26 Mar 2026
  • Current oncology (Toronto, Ont.)
Fertility Preservation Needs of Men Undergoing Cancer Treatment: An Explorative Qualitative Study.
  • 26 Mar 2026
  • Current oncology (Toronto, Ont.)
Suboptimal Adherence to Hereditary Cancer Risk Management Guidelines: A Cohort Study of High-Risk Individuals in Newfoundland and Labrador, Canada.
  • 26 Mar 2026
  • Current oncology (Toronto, Ont.)
Investigating the Secreted Proteome of Primary and Metastatic Human Brain Tumour Explants Maintained on a Miniaturised Perfusion Device.
  • 25 Mar 2026
  • Current oncology (Toronto, Ont.)
CDKN2A/p16 Exon 2 Hypermethylation in Lung Squamous Cell Carcinoma Associated with Interstitial and Emphysematous Lung Diseases: A Comparative Analysis of Tumor, Adjacent and Distant Lung Tissues.
  • 27 Mar 2026
  • Current oncology (Toronto, Ont.)
E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progression.
  • 26 Mar 2026
  • Current oncology (Toronto, Ont.)
Real-World Outcomes of First-Line Cetuximab and Platinum-Based Chemotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Observational Study and Literature Review.
  • 26 Mar 2026
  • Current oncology (Toronto, Ont.)
Fertility Preservation Needs of Men Undergoing Cancer Treatment: An Explorative Qualitative Study.
  • 26 Mar 2026
  • Current oncology (Toronto, Ont.)
Suboptimal Adherence to Hereditary Cancer Risk Management Guidelines: A Cohort Study of High-Risk Individuals in Newfoundland and Labrador, Canada.
  • 26 Mar 2026
  • Current oncology (Toronto, Ont.)
Investigating the Secreted Proteome of Primary and Metastatic Human Brain Tumour Explants Maintained on a Miniaturised Perfusion Device.
  • 25 Mar 2026
  • Current oncology (Toronto, Ont.)

FAQs on Current Oncology